Publications | USF Parkinson's Disease and Movement Disorders Center

2016

Hauser, RA, S Heritier, GJ Rowse, LA Arthur Hewitt, and SH Isaacson. 2016. “Droxidopa and Reduced Falls in a Trial of Parkinson Patients With Neurogenic Orthostatic Hypotension. Clin Neuropharmacol 2016;39:220-6.”. Clin Neuropharmacol.

Hauser, RA, CW Olanow, B Dzyngel, T Bilbault, H Shill, S Isaacson, J Dubow, and A Agro. 2016. “Sublingual Apomorphine (APL-130277) for the Acute Conversion of OFF to ON in Parkinson’s Disease. Mov Disord 2016;31:1366-72.”. Mov Disord.

Rascol, O, RA Hauser, F Stocchi, CJ Fitzer-Attas, Y Sidi, V Abler, CW Olanow, and AFU Investigators. 2016. “Long-Term Effects of Rasagiline and the Natural History of Treated Parkinson’s Disease. Mov Disord 2016;31:1489-1496.”. Mov Disord.

Espay, AJ, PA LeWitt, RA Hauser, A Merola, M Masellis, and AE Lang. 2016. “Neurogenic Orthostatic Hypotension and Supine Hypertension in Parkinson’s Disease and Related Synucleinopathies: Prioritisation of Treatment Targets. Lancet Neurol 2016;15:954-66.”. Lancet Neurol.

Francois, C, GJ Rowse, LA Hewitt, P Vo, and RA Hauser. 2016. “Analysis of Number Needed to Treat for Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension. BMC Neurol 2016;16:143.”. BMC Neurol.

Augustine, EF, ER Dorsey, RA Hauser, JJ Elm, BC Tilley, and KK Kieburtz. 2016. “Communicating With Participants During the Conduct of Multi-Center Clinical Trials. Clin Trials 2016;13:592-596.”. Clin Trials.

Wills, AA, JJ Elm, R Ye, KL Chou, SA Parashos, RA Hauser, I Bodis-Wollner, et al. 2016. “Cognitive Function in 1736 Participants in NINDS Exploratory Trials in PD Long-Term Study-1. Parkinsonism Relat Disord 2016;33:127-133.”. Parkinsonism Relat Disord.

2015

Stegemoller, EL, P Schmidt, and . 2015. “How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease? Arch Phys Med Rehabil 2015;96:1728-32.”. Arch Phys Med Rehabil.

Simuni, T, C Caspell-Garcia, C Coffey, LM Chahine, S Lasch, WH Oertel, G Mayer, et al. 2015. “Correlates of Excessive Daytime Sleepiness in de Novo Parkinson’s Disease: A Case Control Study. Mov Disord 2015;30:1371-81.”. Mov Disord.

Investigators, FS-ZONE. 2015. “Pioglitazone in Early Parkinson’s Disease: A Phase 2, Multicentre, Double-Blind, Randomised Trial. NINDS Exploratory Trials in Parkinson Disease (NET-PD). Lancet Neurol 2015;14:795-803.”. Lancet Neurol.